Search Within

William K Kelly

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
  3. Book Section (1)
Groups
  1. Department of Medicine (11)
  2. GSK Faculty (11)
  3. Genitourinary Oncology Service (11)
  4. Human Oncology and Pathogenesis Program (11)
  5. Solid Tumor Oncology Division (11)
  6. Hematologic Malignancies, Division of (10)

More Groups

People
  1. Howard Scher (10)
  2. Michael Morris (10)
  3. Susan Slovin (10)
  4. David Solit (9)
  5. Anthony De La Cruz (6)
  6. Tracy Smart-Curley (6)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2007 (1)
  4. 2005 (3)
  5. 2004 (1)
  6. 2003 (3)

More Years

Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer (2)
  3. Clinical Cancer Research (2)
  4. Annals of Oncology (1)
  5. EJC Supplements (1)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. Wiley Blackwell (2)
  4. Lippincott Williams & Wilkins (1)
  5. Oxford University Press (1)
  6. Pergamon-Elsevier Science Ltd (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
    Journal Article

    Solit, D. B.; Ivy, S. P.; Kopil, C.; Sikorski, R.; Morris, M. J.; Slovin, S. F.; Kelly, W. K.; Delacruz, A.; Curley, T.; Heller, G.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
    Journal Article

    Morris, M. J.; Divgi, C. R.; Pandit-Taskar, N.; Batraki, M.; Warren, N.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma
    Journal Article

    Morris, M. J.; Smaletz, O.; Solit, D.; Kelly, W. K.; Slovin, S.; Flombaum, C.; Curley, T.; Delacruz, A.; Schwartz, L.; Fleisher, M.; more...
    Cancer (2004)

    Fulltext@MSK | Save
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma
    Journal Article

    Solit, D. B.; Morris, M.; Slovin, S.; Curley, T.; Schwartz, L.; Larson, S.; Kattan, M. W.; Hartley-Asp, B.; Scher, H. I.; Kelly, W. K.
    Cancer (2003)

    Fulltext@MSK | Save
  • Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration
    Journal Article

    Smaletz, O.; Galsky, M.; Scher, H. I.; Delacruz, A.; Slovin, S. F.; Morris, M. J.; Solit, D. B.; Davar, U.; Schwartz, L.; Kelly, W. K.
    Annals of Oncology (2003)

    Fulltext@MSK | Save